AstraZeneca Pushes to Protect Crestor From Generic Competition
The drug maker is trying to get its popular anticholesterol pill approved to treat children who have a rare disease characterized by high cholesterol.
Source: NYT Health - Category: Consumer Health News Authors: ANDREW POLLACK Tags: Crestor (Drug) Law and Legislation Cholesterol AstraZeneca PLC Drugs (Pharmaceuticals) Children and Childhood Generic Brands and Products Food and Drug Administration Source Type: news
More News: AstraZeneca | Children | Cholesterol | Crestor | Food and Drug Administration (FDA) | Health | Rare Diseases | Rosuvastatin